Automated Quantitative Stress Perfusion Cardiac Magnetic Resonance in Pediatric Patients

Cian M Scannell1, Hadeer Hasaneen1, Gerald Greil2

  • 1School of Biomedical Engineering and Imaging Sciences, St Thomas' Hospital, King's College London, London, United Kingdom.

Frontiers in Pediatrics
|September 20, 2021
PubMed

Insights

Fully automated stress myocardial perfusion cardiac magnetic resonance (CMR) is feasible in children. This technique accurately quantifies myocardial blood flow (MBF) and can assess ischemia in pediatric heart conditions.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Medical Imaging

Background:

  • Myocardial ischemia in children can result from congenital and acquired heart diseases.
  • Untreated ischemia may lead to adverse cardiac events.
  • Accurate assessment of pediatric myocardial ischemia is crucial.

Purpose of the Study:

  • To assess the feasibility of automated, high-resolution, quantitative stress myocardial perfusion cardiac magnetic resonance (CMR) in pediatric patients.
  • To evaluate the agreement between automated CMR-derived myocardial blood flow (MBF) and coronary anatomical status.
  • To explore the utility of this technique in diagnosing ischemia in children with heart conditions.

Main Methods:

  • Retrospective analysis of 16 dual-bolus stress perfusion CMR scans from 14 pediatric patients.
  • Automated processing and quantification of perfusion CMR images using an adult-validated pipeline.
  • Comparison of automated MBF with coronary anatomical assessment (CMR, CT, or X-ray angiography).

Main Results:

  • Automated perfusion quantification was successful in 15 out of 16 scans.
  • Myocardial territories supplied by coronary arteries with medium/large aneurysms or stenosis showed significantly reduced MBF.
  • Reduced MBF was observed compared to territories with unaffected coronaries or small aneurysms (p < 0.001 and p = 0.002, respectively).

Conclusions:

  • Automated CMR-derived MBF quantification is feasible and reliable in pediatric patients.
  • This technology offers a potential for objective, non-invasive assessment of myocardial ischemia in children.
  • It can aid in the evaluation of pediatric patients with congenital and acquired heart diseases.